A Prospective Multicenter Clinical Investigation Evaluating the Accuracy of the Trimline Design When Treated With SureSmile® Aligners.
NCT ID: NCT07290790
Last Updated: 2025-12-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
90 participants
INTERVENTIONAL
2025-12-15
2028-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Extended trimline design
SureSmile® Clear Aligner (Group 3) with extended trimline design (2 mm)
SureSmile® Clear Aligners
SureSmile® Clear Aligners are Custom-made (EU)/patient matched (US) medical devices made to fit appliance with different diameters and lengths to accommodate subjects with different mouth shapes and sizes.
This clinical investigation consists of three different trimline designs groups:
* SureSmile aligner Scallop trimline design
* SureSmile aligner Straight trimline design
* SureSmile aligner Straight extended trimline design
All pre-treatment, treatment, and post-treatment protocols and materials used in all groups are identical, except for the type of trimline design.
Scalloped trimline design
SureSmile® Clear Aligner (Group 1) with scalloped trimline design
SureSmile® Clear Aligners
SureSmile® Clear Aligners are Custom-made (EU)/patient matched (US) medical devices made to fit appliance with different diameters and lengths to accommodate subjects with different mouth shapes and sizes.
This clinical investigation consists of three different trimline designs groups:
* SureSmile aligner Scallop trimline design
* SureSmile aligner Straight trimline design
* SureSmile aligner Straight extended trimline design
All pre-treatment, treatment, and post-treatment protocols and materials used in all groups are identical, except for the type of trimline design.
Straight trimline design
SureSmile® Clear Aligner (Group 2) with straight trimline design
SureSmile® Clear Aligners
SureSmile® Clear Aligners are Custom-made (EU)/patient matched (US) medical devices made to fit appliance with different diameters and lengths to accommodate subjects with different mouth shapes and sizes.
This clinical investigation consists of three different trimline designs groups:
* SureSmile aligner Scallop trimline design
* SureSmile aligner Straight trimline design
* SureSmile aligner Straight extended trimline design
All pre-treatment, treatment, and post-treatment protocols and materials used in all groups are identical, except for the type of trimline design.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SureSmile® Clear Aligners
SureSmile® Clear Aligners are Custom-made (EU)/patient matched (US) medical devices made to fit appliance with different diameters and lengths to accommodate subjects with different mouth shapes and sizes.
This clinical investigation consists of three different trimline designs groups:
* SureSmile aligner Scallop trimline design
* SureSmile aligner Straight trimline design
* SureSmile aligner Straight extended trimline design
All pre-treatment, treatment, and post-treatment protocols and materials used in all groups are identical, except for the type of trimline design.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject has signed and dated the informed consent form (ICF) .
* Subject aged 18 years or above at time of informed consent.
* Subject has permanent dentition (i.e., all 2nd molars).
* Subject with a dental malocclusion, consistent with Levels 1 and 2 case complexity and within the clinical references as defined in the SureSmile Case Selection Guide.
* Crowding or spacing must be ≤6mm present in one or both arches consistent with level 1 and 2 of case complexity.
* Midline deviation must be ≤3 mm consistent with level 1 and 2 of case complexity.
* Overjet must be ≤4 mm consistent with level 1 and 2 case complexity.
* Overbite must be ≤3 mm consistent with level 1 and 2 case complexity.
* Anterior open bite must be ≤1 mm, consistent with level 1 and 2 case complexity.
Exclusion Criteria
* Subject that presents a dental malocclusion classified as level 3 case complexity, as defined in the SureSmile Case Selection Guide.
* Subjects who have completed aligner therapy within the last 12 months or who are in active orthodontic treatment.
* Subjects with active periodontal disease or other unresolved dental conditions such as active cavities, active periodontal disease.
* Subjects with treatment plans requiring transverse correction requiring expansion greater than 4 mm per arch or 2 mm per quadrant, or any skeletal transverse correction.
* Treatment plans requiring sagittal correction exceeding a half-cusp discrepancy (i.e., \>½ unit) in molar or canine relationships.
* Subjects with treatment plans require vertical correction beyond Level 1 and 2 thresholds (i.e., overbite \>3 mm or anterior/posterior open bite \>1 mm), or vertical elastics exceeding 3 mm.
* TMJ (Temporo-Mandibular Join) disorders or history of headaches or migraines.
* Participants with known history of plastic allergies.
* Subjects with presence of skeletal discrepancies necessitating orthognathic surgery, rapid palatal expansion, other orthopedic intervention, unilateral or bilateral cross-bites, mandibular deviations in association with the diagnosed malocclusion
* The use of TADs (Temporary Anchor Devices), plates, other fixed anchorage ancillaries or the use of functional appliances (distalizers, growth modification devices), any approach involving orthopedic or skeletal sagittal correction or the use of hybrid fixed appliances are not considered part of the scope of this clinical investigation and these subjects are not eligible.
* Uncontrolled para-functional habits, e.g., bruxism.
* Any other condition that would make the subject unsuitable for participation, including but not limited to:
* Unstable psychiatric illness.
* Recent myocardial infarction (\< 3 months\*).
* Recent cerebrovascular accident (\< 3 months\*).
* Recent cardiac-valvular prosthesis placement (\< 3 months\*).
* Hemorrhagic diathesis.
* Severe liver dysfunction.
* Known or suspected current malignancy.
* Known pregnancy at the time of enrolment.
* Previous enrolment in the present clinical investigation.
* Involvement in the planning and conduct of the clinical investigation (applies to both Dentsply Sirona personnel and the clinical investigation site).
* Participation in another clinical investigation that may interfere with the present clinical investigation.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dentsply Sirona Implants and Consumables
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Costanzo Orthodontics
Fresno, California, United States
Center for Orthodontic Excellence
Princeton Junction, New Jersey, United States
Brush 365 Dental
Frisco, Texas, United States
Clinica dental Francesc Batlle
Barcelona, , Spain
The Sanford
Bexleyheath, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Chichetti
Role: primary
Shah
Role: primary
Mahmood
Role: primary
Salman
Role: primary
Shaffie
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C-OR-25-002
Identifier Type: -
Identifier Source: org_study_id